Alcon AG (ALC)
NYSE · Healthcare · Medical Instruments & Supplies
Alcon AG is a Healthcare company with a market capitalization of $33.07B, a trailing P/E ratio of 40.6, and a dividend yield of 0.53%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $0.85 | $0.82 | +3.7% |
| Q4 2025 | February 24, 2026 | $0.78 | $0.78 | -0.5% |
| Q3 2025 | November 11, 2025 | $0.79 | $0.77 | +2.6% |
| Q2 2025 | August 19, 2025 | $0.76 | $0.71 | +7.0% |
| Q1 2025 | May 13, 2025 | $0.73 | $0.76 | -4.0% |
| Q4 2024 | February 25, 2025 | $0.72 | $0.72 | +0.0% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is Alcon AG's market cap?
As of June 29, 2026, Alcon AG (ALC) has a market capitalization of $33.07B.
What is Alcon AG's P/E ratio?
Alcon AG trades at a trailing price-to-earnings (P/E) ratio of 40.6. Its forward P/E is 19.9.
Does Alcon AG pay a dividend?
Yes — Alcon AG pays a dividend yielding 0.53%, an annual payout of $0.35 per share.
What sector is ALC in?
Alcon AG is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was Alcon AG's revenue?
In its latest reported fiscal year (ending December 31, 2025), Alcon AG reported revenue of $10.40B and net income of $980.00M.
Ask your own questions about ALC
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.